GenMont Biotech Incorporation (TPE:3164)
Taiwan · Delayed Price · Currency is TWD 16.15
-0.10 (-0.62%)
Aug 4, 2026, 1:30 PM CST
TPE:3164 Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 390.95 | 401.23 | 385.37 | 318.02 | 368.55 | 427.93 |
Revenue Growth | 6.12% | 4.11% | 21.18% | -13.71% | -13.88% | 31.59% |
Gross Profit Gross Profit Growth | 237.27 | 251.63 | 238.18 | 211.19 | 256.72 | 299.33 |
Operating Income Operating Income Growth | 40.86 | 57.75 | 40.63 | 6.99 | 61.97 | 125.04 |
Net Income Net Income Growth | 44.89 | 57.2 | 57.25 | 32.99 | 56.98 | 113.13 |
Earnings Per Share EPS Growth | 0.52 | 0.66 | 0.66 | 0.38 | 0.66 | 1.30 |
EPS Growth | 15.55% | 0% | 73.68% | -42.40% | -49.25% | 88.41% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Genmont (China) Genmont (China) Growth | 46.69 | 40.21 | 8.57 | - | - |
Genmont Biotech Inc. Genmont Biotech Inc. Growth | 354.54 | 345.16 | 309.45 | 368.55 | 427.93 |
Total Total Growth | 401.23 | 385.37 | 318.02 | 368.55 | 427.93 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 387.45 | 365.36 | 358.64 | 328.3 | 400.94 | 421.73 |
Total Debt Total Debt Growth | 119.74 | 110.31 | 118.61 | 58.31 | 34.55 | 32.73 |
Net Cash (Debt) Net Cash Growth | 267.71 | 255.05 | 240.03 | 270 | 366.4 | 389 |
Net Cash Growth | -2.27% | 6.26% | -11.10% | -26.31% | -5.81% | -9.70% |
Net Cash Per Share Net Cash Per Share Growth | 3.10 | 2.95 | 2.77 | 3.12 | 4.23 | 4.48 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 57.58 | 73.6 | 123.95 | 34.6 | 136.98 | 111.66 |
Capital Expenditures CapEx Growth | -3.49 | -3.41 | -44.05 | -33.31 | -71.19 | -116.94 |
Free Cash Flow Free Cash Flow Growth | 54.09 | 70.19 | 79.89 | 1.29 | 65.79 | -5.28 |
Free Cash Flow Growth | -44.35% | -12.14% | 6088.38% | -98.04% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 60.69% | 62.72% | 61.80% | 66.41% | 69.66% | 69.95% |
Operating Margin | 10.45% | 14.39% | 10.54% | 2.20% | 16.81% | 29.22% |
Pretax Margin | 12.42% | 15.87% | 16.79% | 8.86% | 17.98% | 32.58% |
Profit Margin | 11.48% | 14.26% | 14.86% | 10.37% | 15.46% | 26.44% |
FCF Margin | 13.84% | 17.49% | 20.73% | 0.41% | 17.85% | -1.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.800 | 0.800 | 0.800 | 0.500 | 0.700 | 1.100 |
Dividend Per Share Growth | 0% | 0% | 60.00% | -28.57% | -36.36% | 57.14% |
Dividend Yield | 4.92% | 4.56% | 4.29% | 2.24% | 3.36% | 5.37% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 31.05 | 27.59 | 30.52 | 64.77 | 35.93 | 18.59 |
P/FCF Ratio | 25.68 | 22.49 | 21.87 | 1655.18 | 31.11 | - |
PS Ratio | 3.55 | 3.93 | 4.54 | 6.72 | 5.55 | 4.92 |